Logo image of CXAI

CXAPP INC (CXAI) Stock Fundamental Analysis

NASDAQ:CXAI - Nasdaq - US23248B1098 - Common Stock - Currency: USD

1.5  -0.07 (-4.46%)

After market: 1.52 +0.02 (+1.33%)

Fundamental Rating

2

Taking everything into account, CXAI scores 2 out of 10 in our fundamental rating. CXAI was compared to 284 industry peers in the Software industry. CXAI has a bad profitability rating. Also its financial health evaluation is rather negative. CXAI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CXAI has reported negative net income.
CXAI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CXAI reported negative net income in multiple years.
CXAI had a negative operating cash flow in each of the past 5 years.
CXAI Yearly Net Income VS EBIT VS OCF VS FCFCXAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

With a Return On Assets value of -171.46%, CXAI is not doing good in the industry: 94.93% of the companies in the same industry are doing better.
The Return On Equity of CXAI (-379.24%) is worse than 86.59% of its industry peers.
Industry RankSector Rank
ROA -171.46%
ROE -379.24%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CXAI Yearly ROA, ROE, ROICCXAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 1K 2K 3K 4K

1.3 Margins

The Gross Margin of CXAI (80.63%) is better than 82.61% of its industry peers.
CXAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CXAI Yearly Profit, Operating, Gross MarginsCXAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

CXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
CXAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CXAI Yearly Shares OutstandingCXAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2M 4M 6M
CXAI Yearly Total Debt VS Total AssetsCXAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -3.75, we must say that CXAI is in the distress zone and has some risk of bankruptcy.
CXAI's Altman-Z score of -3.75 is on the low side compared to the rest of the industry. CXAI is outperformed by 82.25% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that CXAI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.46, CXAI is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -3.75
ROIC/WACCN/A
WACC14%
CXAI Yearly LT Debt VS Equity VS FCFCXAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

CXAI has a Current Ratio of 0.45. This is a bad value and indicates that CXAI is not financially healthy enough and could expect problems in meeting its short term obligations.
CXAI has a worse Current ratio (0.45) than 94.20% of its industry peers.
CXAI has a Quick Ratio of 0.45. This is a bad value and indicates that CXAI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.45, CXAI is doing worse than 94.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
CXAI Yearly Current Assets VS Current LiabilitesCXAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 1M 2M 3M

More info and screens

4

3. Growth

3.1 Past

CXAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.98%.
CXAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.43%.
EPS 1Y (TTM)-38.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-346.15%
Revenue 1Y (TTM)27.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.18%

3.2 Future

Based on estimates for the next years, CXAI will show a very strong growth in Earnings Per Share. The EPS will grow by 22.47% on average per year.
CXAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 60.82% yearly.
EPS Next Y-6.9%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.31%
Revenue Next 2Y60.82%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CXAI Yearly Revenue VS EstimatesCXAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CXAI Yearly EPS VS EstimatesCXAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CXAI. In the last year negative earnings were reported.
Also next year CXAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CXAI Price Earnings VS Forward Price EarningsCXAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CXAI Per share dataCXAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as CXAI's earnings are expected to grow with 22.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CXAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CXAPP INC

NASDAQ:CXAI (2/21/2025, 8:11:31 PM)

After market: 1.52 +0.02 (+1.33%)

1.5

-0.07 (-4.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)04-14 2025-04-14/bmo
Inst Owners7.2%
Inst Owner Change9.6%
Ins Owners22.15%
Ins Owner Change80.89%
Market Cap27.96M
Analysts82.86
Price Target5.1 (240%)
Short Float %11.27%
Short Ratio0.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.09%
Min EPS beat(2)-30.72%
Max EPS beat(2)-23.46%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-3.81%
Max Revenue beat(2)3.32%
Revenue beat(4)1
Avg Revenue beat(4)-7.34%
Min Revenue beat(4)-22.51%
Max Revenue beat(4)3.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)-4.35%
EPS NQ rev (3m)-4.35%
EPS NY rev (1m)-15.89%
EPS NY rev (3m)-15.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.88
P/FCF N/A
P/OCF N/A
P/B 1.96
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.34
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.39
BVpS0.77
TBVpS-0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -171.46%
ROE -379.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.63%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.47%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z -3.75
F-Score2
WACC14%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-346.15%
EPS Next Y-6.9%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.18%
Revenue Next Year29.31%
Revenue Next 2Y60.82%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1097.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1091.41%
OCF growth 3YN/A
OCF growth 5YN/A